Nilutamide structure
|
Common Name | Nilutamide | ||
---|---|---|---|---|
CAS Number | 63612-50-0 | Molecular Weight | 317.221 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C12H10F3N3O4 | Melting Point | 1490C | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS06, GHS08 |
Signal Word | Danger |
Use of NilutamideNilutamide (Nilandron) is a non-steroidal anti-androgen drug proposed in the treatment of metastatic prostatic carcinoma[1][2]. |
Name | nilutamide |
---|---|
Synonym | More Synonyms |
Description | Nilutamide (Nilandron) is a non-steroidal anti-androgen drug proposed in the treatment of metastatic prostatic carcinoma[1][2]. |
---|---|
Related Catalog | |
References |
[2]. Ask K, et al. Metabolism of nilutamide in rat lung. Biochem Pharmacol. 2006 Jan 12;71(3):377-85. |
Density | 1.5±0.1 g/cm3 |
---|---|
Melting Point | 1490C |
Molecular Formula | C12H10F3N3O4 |
Molecular Weight | 317.221 |
Exact Mass | 317.062347 |
PSA | 95.23000 |
LogP | 2.23 |
Index of Refraction | 1.524 |
Storage condition | Store at RT |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H360 |
Precautionary Statements | P201-P301 + P310-P308 + P313 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic; |
Risk Phrases | R60;R25 |
Safety Phrases | 53-36/37/39-45 |
RIDADR | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | NI9453300 |
HS Code | 2933990090 |
~% Nilutamide CAS#:63612-50-0 |
Literature: US2012/142937 A1, ; Page/Page column 7 ; |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Phase I and phase II reductive metabolism simulation of nitro aromatic xenobiotics with electrochemistry coupled with high resolution mass spectrometry.
Anal. Bioanal. Chem 406(28) , 7253-60, (2014) Electrochemistry combined with (liquid chromatography) high resolution mass spectrometry was used to simulate the general reductive metabolism of three biologically important nitro aromatic molecules:... |
|
Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.
J. Phys. Chem. B 118(33) , 9974-82, (2014) Amorphous forms of drugs are increasingly being used to deliver poorly water-soluble compounds. Therefore, understanding the magnitude and origin of differences in crystallization kinetics is highly i... |
|
High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
Assay Drug Dev. Technol. 12(7) , 395-418, (2014) The androgen receptor-transcriptional intermediary factor 2 (AR-TIF2) positional protein-protein interaction (PPI) biosensor assay described herein combines physiologically relevant cell-based assays ... |
MFCD00864670 |
2,4-Imidazolidinedione, 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]- |
Nilandron |
Nilandrone |
5,5-Dimethyl-3-[4-nitro-3-(trifluormethyl)phenyl]imidazolidin-2,4-dion |
5,5-diméthyl-3-[4-nitro-3-(trifluorométhyl)phényl]imidazolidine-2,4-dione |
Nilutamide |
Anandron |
5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione |
Nilutamida |
5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione |
Nilutamidum |